Observation on effect of yugan granule in treating patients of chronic hepatitis B with basic core promoter mutant hepatitis B virus.
- Author:
Chao-liang XIE
1
;
Ze-yong SHAO
Author Information
- Publication Type:Journal Article
- MeSH: Adolescent; Adult; Drugs, Chinese Herbal; therapeutic use; Female; Hepatitis B e Antigens; blood; Hepatitis B virus; genetics; Hepatitis B, Chronic; drug therapy; immunology; virology; Humans; Male; Middle Aged; Phytotherapy; Point Mutation; Promoter Regions, Genetic; genetics; Viral Core Proteins; genetics
- From: Chinese Journal of Integrated Traditional and Western Medicine 2002;22(7):502-504
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo observe the effect of Yugan Granule (YGG) in treating patients of chronic hepatitis B infected with basic core promoter (BCP) mutant HBV.
METHODSBCP mutation was detected by microwell liquid hybridization combined with enzyme linked immunosorbent assay (ELISA) and 46 patients were confirmed to be the mutant positive (Group A), and 69 the mutant negative (Group B). All patients were treated by YGG and the clinical symptoms and laboratory parameters before and after treatment were observed.
RESULTSThe scores of symptoms and serum levels of alanine transaminase (ALT) and total bilirubin (TBil) were decreased markedly in both groups after treatment. The HBeAg negative conversion rate in Group A was 60%, obviously higher than that in Group B (30%, P < 0.05), while HBV-DNA negative conversion rate between the two groups had the insignificant difference. The overall efficacy was similar in the two groups.
CONCLUSIONYGG could remarkably alleviate the symptoms, reduce serum levels of ALT and TBil, and showed the effect of anti-HBV with the same efficacy both to BCP mutant and wild strain HBV infected patients.
